4.1 Review

Langerhans cell sarcoma involving skin and showing epidermotropism: A comprehensive review

期刊

JOURNAL OF CUTANEOUS PATHOLOGY
卷 48, 期 4, 页码 547-557

出版社

WILEY
DOI: 10.1111/cup.13803

关键词

Langerhans cell histiocytosis; Langerhans cell sarcoma; melanoma; skin

向作者/读者索取更多资源

Langerhans cell sarcoma (LCS) is a rare and aggressive tumor with a low overall survival rate. This case presents a unique instance of LCS with epidermotropism, emphasizing the importance of immunophenotyping in diagnosis. Early recognition is crucial in LCS cases due to the tendency for recurrence and metastasis.
Langerhans cell sarcoma (LCS) is rare and aggressive; patients have an overall survival rate of less than 50%. We present a 62-year-old man with a history of superficial spreading melanoma of the upper back with sentinel lymph node metastasis, Langerhans cell histiocytosis, and LCS. The patient presented with erythematous papules and scaly areas on his face, neck, arms, chest, abdomen, and legs. A skin biopsy revealed a proliferation of large neoplastic cells involving the dermis and with epidermotropism. These cells had atypical bean-shaped nuclei, with ample cytoplasm and abundant mitotic figures including atypical forms. Immunohistochemical studies showed the tumor to be diffusely positive for CD1a, S100 protein, and langerin (CD207) and negative for melanocytic markers. Some tumor cells were positive for cyclin D1. A diagnosis of LCS involving the skin was established. The present study is a very unusual case of LCS showing epidermotropism. The patient's history of metastatic melanoma posed additional challenges for diagnosis, underlying the need of immunophenotyping in these cases. Consensus for optimal standard therapy has not been established in LCS, and thus, early recognition is important since these neoplasms tend to recur and metastasize. LCS in skin is discussed and published cases are comprehensively reviewed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据